XRAY Earnings & Financial Statements
DENTSPLY SIRONA Inc.
$8.74
+$0.29(+3.50%)
39
Overall
60
Value
18
Tech
39
Quality
Market Cap
$1.70B
Volume
1.35M
52W Range
$8.38 - $14.76
Target Price
$12.93
XRAY earnings and financial statements: DENTSPLY SIRONA Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
XRAY Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $3.68B | $3.79B | $3.96B | $3.92B | $4.23B |
| Cost of revenue | $1.84B | $1.83B | $1.88B | $1.79B | $1.88B |
| Operating income | -$422.00M | -$879.00M | -$85.00M | -$937.00M | $608.00M |
| EBITDA | -$46.00M | -$518.00M | $249.00M | -$662.00M | $952.00M |
| Net income | -$598.00M | -$910.00M | -$132.00M | -$950.00M | $411.00M |
| EPS (diluted) | $-3.00 | $-4.48 | $-0.62 | $-4.41 | $1.91 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $5.43B | $5.75B | $7.37B | $7.64B | $9.24B |
| Total liabilities | $4.09B | $3.81B | $4.08B | $3.83B | $4.24B |
| Shareholders’ equity | $1.34B | $1.94B | $3.29B | $3.81B | $5.00B |
| Cash and equivalents | $326.00M | $272.00M | $334.00M | $365.00M | $339.00M |
| Long-term debt | $2.11B | $1.68B | $1.92B | $1.98B | $2.06B |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | $235.00M | $461.00M | $377.00M | $517.00M | $657.00M |
| Capital expenditure | -$131.00M | -$180.00M | -$149.00M | -$149.00M | -$142.00M |
| Free cash flow | $104.00M | $281.00M | $228.00M | $368.00M | $515.00M |
| Dividends paid | $128.00M | $126.00M | $116.00M | $104.00M | $92.00M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | XRAY | $8.74 | +3.5% | 1.35M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |